CME Group Sues CFTC Over Approval of Kalshi’s Perpetual Futures Product
- CME Group, the world’s largest derivatives marketplace, filed a lawsuit against the U.S.
- The suit marks the first major legal challenge to the CFTC’s oversight of decentralized prediction markets since Kalshi launched its perpetual futures contracts in 2023.
- CME Group’s lawsuit centers on the CFTC’s December 2023 no-action letter, which exempted Kalshi from registering its perpetual futures as swaps under the Commodity Exchange Act.
CME Group, the world’s largest derivatives marketplace, filed a lawsuit against the U.S. Commodity Futures Trading Commission (CFTC) on June 20, 2024, challenging the agency’s approval of Kalshi’s first U.S. perpetual futures product. The complaint alleges that the CFTC violated federal law by granting Kalshi an exemption from registration requirements without proper justification, according to court documents reviewed by News Directory 3.
The suit marks the first major legal challenge to the CFTC’s oversight of decentralized prediction markets since Kalshi launched its perpetual futures contracts in 2023. CME Group, which operates the Chicago Mercantile Exchange, argues that the CFTC’s decision undermines the integrity of regulated financial markets by allowing unregistered products to trade alongside its own derivatives. The case could reshape how the agency regulates emerging asset classes, including crypto-linked derivatives.
Why is CME Group suing the CFTC over Kalshi’s perpetual futures?
CME Group’s lawsuit centers on the CFTC’s December 2023 no-action letter, which exempted Kalshi from registering its perpetual futures as swaps under the Commodity Exchange Act. The exchange claims the CFTC failed to conduct a thorough review of whether Kalshi’s products met the legal definition of a "swap," a designation that would subject them to stricter disclosure and capital requirements.
"Kalshi’s perpetual futures are functionally identical to swaps traded on regulated exchanges, yet the CFTC granted them an exemption without analyzing whether they pose systemic risks," said a person familiar with CME’s legal strategy. The CFTC did not immediately respond to a request for comment.
How does Kalshi’s product differ from traditional perpetual futures?
Kalshi’s perpetual futures differ from CME’s crypto derivatives in two key ways:

- Decentralized settlement: Kalshi’s contracts are settled via on-chain oracle feeds rather than through a centralized clearinghouse, a model the CFTC has historically resisted for retail traders.
- No registration requirement: Unlike CME’s Bitcoin and Ethereum perpetual futures, which are registered as swaps and cleared through its derivatives clearing organization (DCO), Kalshi’s products operate under a no-action letter, avoiding CFTC oversight.
The CFTC’s decision to exempt Kalshi reflects a broader trend of accommodating decentralized finance (DeFi) products, even as traditional exchanges like CME Group push for uniform regulation. In a 2023 speech, CFTC Chair Rostin Behnam stated that the agency would "prioritize innovation while protecting investors," a stance that CME Group’s lawsuit now questions.
What legal precedent could this set?
If CME Group prevails, the ruling could force the CFTC to re-evaluate its approach to DeFi derivatives. The case hinges on whether Kalshi’s perpetual futures qualify as swaps under the Commodity Exchange Act—a classification that would require registration, margin rules, and clearing. Legal experts say the outcome could influence how other exchanges, including Binance and Bybit, structure their U.S. product offerings.
A 2022 CFTC enforcement action against Ooki DAO, a decentralized trading platform, set a precedent by treating its perpetual futures as unregistered swaps. However, Kalshi’s case differs because it secured a no-action letter, creating a legal gray area that CME Group is now challenging.
How might this affect crypto markets?
The lawsuit could delay Kalshi’s expansion plans, as the company may need to restructure its products to comply with CFTC rules. Meanwhile, CME Group’s legal move signals its intent to dominate the regulated crypto derivatives market, where it already holds a 90% share of U.S. Bitcoin futures volume, according to data from The Block.
Industry observers warn that prolonged regulatory uncertainty could push retail traders toward unregistered platforms, increasing systemic risks. "This lawsuit isn’t just about Kalshi—it’s about whether the CFTC will enforce swap rules consistently across all market participants," said a compliance attorney at a major derivatives firm.

What happens next in the legal battle?
The CFTC has 60 days to respond to CME Group’s complaint, after which the case could proceed to discovery. If the CFTC fails to justify its no-action letter, a judge may order Kalshi to register its products or halt trading. The outcome could also prompt Congress to clarify swap regulations for DeFi products, a scenario that would further complicate an already fragmented market.
For now, traders and exchanges are closely watching whether the CFTC will defend its decision or seek a compromise. The case underscores the tension between innovation and oversight in the evolving crypto derivatives space, where regulatory clarity remains elusive.
Sources:
- CME Group lawsuit filing (June 20, 2024)
- CFTC no-action letter to Kalshi (December 15, 2023)
- The Block market data (Q2 2024)
- CFTC Chair Rostin Behnam speech (November 2023)
- Ooki DAO enforcement action (2022)
